Modern Approaches to Effective Glycaemic Control
The combination of metformin plus a sulfonyurea is broadly used for the treatment of type 2 diabetes. However, many patients on dual therapy still do not achieve glycaemic control. Adding a third oral agent can be an option for patients before initiating insulin therapy. The symposium will focus on the role of vildagliptin in this setting.
Managing obesity in Type 2 Diabetes – what are the options?
Obesity is a complex condition to manage, and is even more challenging for patients with diabetes, particularly those on medications including insulin. This presentation will provide an overview of the treatment options available and the relative merits of each. It will also provide some insights into the practicalities of managing diabetes medications while patients are on restricted eating plans.
The ADEA Standards for Initiating Insulin Therapy in Ambulatory Care Settings (2013) provide health professionals with a process for addressing outcomes, processes and structure around insulin initiation.The symposium will look at both QUM in the context of the use of insulin and discuss the role and scope of practice of the CDE now and in the future